Komori
Maeda Kosen (7821) · FactUpdate to annual R&D expenditure

Group-wide research and development activities: ¥432 million

First written in FY2020-Q3. . Latest entry: FY2026.

18entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2020-Q3 – FY20262020: 220202021: 420212022: 320222023: 320232024: 220242025: 220252026: 22026
Same theme, other companies
Continued company-wide R&D activities and resource investmentA theme 202 companies write about · 0 as a headwind · 215 as a tailwind

92 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 217 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Update to annual R&D expenditureAnnual report

    「The total amount of research and development expenses for the consolidated fiscal year was ¥841 million.」

    Research and development expenses increased from ¥567 million in the previous fiscal year to ¥841 million.
  2. FY2026-H1Updated to interim-period R&D expenditureAnnual report

    「The amount of group-wide research and development activities for the current interim consolidated accounting period was ¥409 million.」

    The amount of group-wide research and development activities was updated to ¥409 million for the interim period. The company stated that there were no material changes in the status of its research and development activities.
  3. FY2025Updated to full-year research and development expensesAnnual report

    「The total amount of research and development expenses for the consolidated fiscal year was ¥567 million.」

    Group-wide research and development expenses were updated to ¥567 million for the full fiscal year.
  4. FY2025-H1Updated to interim-period R&D expenditureAnnual report

    「The amount of group-wide research and development activities for the current interim consolidated accounting period was ¥269 million.」

    The amount of group-wide research and development activities was updated to ¥269 million for the interim period. The company stated that there were no material changes in the status of its research and development activities.
  5. FY2024-Q2Updated to third-quarter research and development expensesAnnual report

    「The amount of group-wide research and development activities for the first nine months of the current consolidated fiscal year was ¥367 million.」

    The amount of group-wide research and development activities was updated to ¥367 million for the first nine months. The company stated that there were no material changes in the status of its research and development activities.
  6. FY2024-Q1Updated to second-quarter research and development expensesAnnual report

    「The amount of group-wide research and development activities for the first six months of the current consolidated fiscal year was ¥247 million. There were no material changes in the status of the group's research and development activities during the first six months of the current consolidated fiscal year.」

    The amount of group-wide research and development activities was updated to ¥247 million for the first six months. The company stated that there were no material changes in the status of its research and development activities.
  7. FY2023-Q4Updated to first-quarter research and development expensesAnnual report

    「The amount of group-wide research and development activities for the first quarter of the current consolidated fiscal year was ¥115 million.」

    The amount of group-wide research and development activities was updated to ¥115 million for the first quarter. The company stated that there were no material changes in the status of its research and development activities.
  8. FY2023-Q2Updated to third-quarter research and development expensesAnnual report

    「The amount of group-wide research and development activities for the first nine months of the current consolidated fiscal year was ¥372 million.」

    The amount of group-wide research and development activities was updated to ¥372 million for the first nine months, and the company stated that there were no material changes in the status of its research and development activities.
  9. FY2023-Q1Updated to second-quarter research and development expensesAnnual report

    「The amount of group-wide research and development activities for the first six months of the current consolidated fiscal year was ¥251 million. There were no material changes in the status of the group's research and development activities during the first six months of the current consolidated fiscal year.」

    Research and development expenses were updated to ¥251 million for the first six months, and the company stated that there were no material changes in the status of its research and development activities.
  10. FY2022-Q4Updated to first-quarter research and development expensesAnnual report

    「The amount of group-wide research and development activities for the first quarter of the current consolidated fiscal year was ¥138 million.」

    The amount of group-wide research and development activities for the first quarter was disclosed as ¥138 million. The company stated that there were no material changes in the status of its research and development activities.
  11. FY2022-Q2Updated to second-quarter research and development expensesAnnual report

    「The amount of group-wide research and development activities for the first six months of the current consolidated fiscal year was ¥338 million. There were no material changes in the status of the group's research and development activities during the first six months of the current consolidated fiscal year.」

    Research and development expenses were updated from ¥200 million for the first quarter to ¥338 million for the first six months, and the company stated that there were no material changes in the status of its activities.
  12. FY2022-Q1Updated to first-quarter research and development expensesAnnual report

    「The amount of group-wide research and development activities for the first quarter of the current consolidated fiscal year was ¥200 million.」

    The group-wide amount of research and development expenses for the first quarter was disclosed as ¥200 million.
  13. FY2021Update to annual R&D expenditureAnnual report

    「The total amount of research and development expenses for the consolidated fiscal year was ¥809 million.」

    Research and development expenses increased from ¥688 million in the previous fiscal year to ¥809 million.
  14. FY2021-Q3Updated to third-quarter research and development expensesAnnual report

    「The amount of group-wide research and development activities for the first nine months of the current consolidated fiscal year was ¥638 million. There were no material changes in the status of the group's research and development activities during the first nine months of the current consolidated fiscal year.」

    Research and development expenses were updated from ¥402 million for the first six months to ¥638 million for the first nine months, and the company stated that there were no material changes in the status of its research and development activities.
  15. FY2021-Q2Updated to second-quarter research and development expensesAnnual report

    「The amount of group-wide research and development activities for the first six months of the current consolidated fiscal year was ¥402 million. There were no material changes in the status of the group's research and development activities during the first six months of the current consolidated fiscal year.」

    The amount of research and development activities was updated from ¥222 million for the first quarter to ¥402 million for the first six months. The company stated that there were no material changes in the activities.
  16. FY2021-Q1Updated to first-quarter research and development expensesAnnual report

    「The amount of group-wide research and development activities for the first quarter of the current consolidated fiscal year was ¥222 million.」

    The disclosure of research and development expenses was updated from the previous full-year amount of ¥688 million to the actual amount of ¥222 million for the first quarter.
  17. FY2020Update to annual R&D expenditureAnnual report

    「The total amount of research and development expenses for the consolidated fiscal year was ¥688 million.」

    Research and development expenses were updated from ¥432 million for the first nine months to ¥688 million for the full fiscal year.
  18. FY2020-Q3First statedAnnual report

    「The amount of group-wide research and development activities for the first nine months of the current consolidated fiscal year was ¥432 million.」

    The amount of group-wide research and development activities for the first nine months of the current consolidated fiscal year was stated as ¥432 million.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Maeda Kosen yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Group-wide research and development activities: ¥432 million | MAEDA KOSEN CO.,LTD. (7821) | Komori